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Abstract
Background
Healthcare workers (HCWs) are at high risk of tuberculosis (TB) infection due to occupa-
tional exposure. It is important to diagnose TB infections in HCWs to prevent nosocomial
transmission, particularly among immunocompromised patients.
Objective
The aim of this study was to analyze the rate of tuberculin skin test (TST) conversion and to
assess the incidence of active TB after the latent TB infection screenings in high-risk HCWs.
Methods
This retrospective cohort study involved 458 HCWs in TB-related departments between
2009 and 2013. All HCWs underwent a TST and a chest radiograph annually; an interferon-
γ release assay (IGRA) was performed on the TST-converted subjects. TST-converted and
IGRA-positive HCWs underwent treatment for latent TB infection.
Results
The TST conversion rate was 30.3% from 2009 to 2011 in two years, 7.4% from 2011 to
2012, and 17.4% from 2012 to 2013. Eleven subjects out of 42 TST converters (26%) were
IGRA-positive; two of them developed into active pulmonary TB during the follow-up period.
Conclusions
There was significant discordance between TST conversion and IGRA results in high-risk
HCWs, and active TB developed only in TST-converted and IGRA-positive HCWs. There-
fore, the combined use of TST and IGRA for periodic monitoring of TB infections in high-risk
HCWs may be useful.
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Introduction
Healthcare workers (HCWs) are at high risk of Mycobacterium tuberculosis infection due to
occupational exposure.[1] The likelihood of tuberculosis (TB) infection in HCWs is influenced
by the patients they care for, type of occupation, the regional prevalence of TB, and the efficacy
of TB infection control programs.[1,2] If HCWs are diagnosed with infectious TB, the impact
of nosocomial TB transmission can be considerable because of immunocompromised patients
in healthcare systems. Therefore, periodic screenings and preventive treatment for latent TB
infection (LTBI) for HCWs at high-risk of TB infection (high-risk HCWs) are recommended.
[3–5]
Tuberculin skin tests (TST) are used worldwide to diagnose LTBI, whereas interferon-γ
release assay (IGRA), which includes QuantiFERON-TB Gold-in-Tube test (QFT-GIT; Qia-
gen, Hilden, Germany) and T.SPOT TB test (Oxford Immunotec, Abingdon, UK) are used in
some countries according to their national TB programs.[3–5] However, no effective method
for periodic screening of LTBI in high-risk HCWs in moderate to high TB burden areas has
been developed. IGRA offers a potential method of serial testing to diagnose LTBI in HCWs,
and it has better specificity than that of TST in one-time screening.[6,7] On the other hand,
using IGRA for serial testing is complicated by lack of data to determine the optimum cut-offs
and to interpret the results.[8–11]
South Korea has an intermediate incidence of TB (80/100 000 of the population per year),
[12] and Bacillus Calmette–Guerin (BCG) vaccination is mandatory within one month of
birth. Although current Korean TB guidelines recommend regular screenings in high-risk
HCWs, no proper method has been established.[13]
Using TST and QFT-GIT, serial LTBI screening in high-risk HCWs has been conducted in
our institution since 2009. The aim of this study was to analyze the LTBI screening data in
high-risk HCWs and to assess the incidence of active pulmonary TB in a tertiary referral hos-
pital in South Korea.
Materials and methods
Study subjects and screening protocol
This study was conducted at Severance Hospital (Seoul, Republic of Korea), a tertiary referral
hospital with approximately 2400 beds. About 600 culture- or smear-positive pulmonary TB
patients are managed annually at this institution.
According to the institution’s policy, all high-risk HCWs were recommended to undergo
an annual TB screening from October 2009. High-risk HCWs were defined as those who are
working at TB-related departments, such as medical intensive care unit, respiratory depart-
ment of ward and outpatient clinic, emergency department, microbiology laboratory, and
radiology department. Each subject underwent a TST, a simple chest radiography, and a medi-
cal interview of comorbidities, previous TB history, work duration, and occupational category
(i.e., physician, nurse, health aide, technician, and others).
We analyzed the screening data of high-risk HCWs who underwent TST at least once
between 2009 and 2013. Four TSTs were performed during the study period because only
chest radiograph was conducted in 2010. In 2009 (T1), 286 high-risk HCWs participated in
the screening. In 2011 (T2), 2012 (T3), and 2013 (T4), 83, 46, and 43 additional high-risk
HCWs newly joined the program, respectively, because of movement from other departments
or new recruitment. (Fig 1A)
QFT-GIT was tested for the TST-converted subjects. Those who showed TST-converted
and QFT-GIT-positive results were strongly recommended to take treatment for latent TB
LTBI screening in healthcare workers
PLOS ONE | https://doi.org/10.1371/journal.pone.0204035 September 20, 2018 2 / 11
Competing interests: The authors have declared
that no competing interests exist.
Fig 1. Study population of (A) total HCWs and (B) HCWs with two-step baseline TSTs. HCWs, healthcare workers; TST, tuberculin skin
test; T1, annual screening in 2009; T2, in 2011; T3, in 2012; T4, in 2013.
https://doi.org/10.1371/journal.pone.0204035.g001
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infection with either 3 months of isoniazid and rifampicin, 4 months of rifampicin, or 9
months of isoniazid. High-risk HCWs were followed for the development of active pulmonary
TB after 2013 based on the medical records and the results of regular medical exam for all
employees.
The study protocol was reviewed and approved by the Institutional Review Board of Sever-
ance Hospital, and informed consent was waived by the committee. (4-2017-1055)
TST and IGRA
A TST was performed on the forearm in accordance with the Mantoux method using a 0.1mL
of 2 TU of purified protein derivative RT 23 (Statens Serum Institute, Copenhagen, Denmark).
The transverse diameter of the induration was measured in millimeters 48 to 72 hours later. A
positive TST was defined as an induration 10 mm in diameter. TST conversion was defined
as a baseline TST induration < 10 mm and a follow-up TST induration 10 mm with an
increment of 6 mm relative to baseline.[13] Follow-up TST was repeated for subjects with
previous negative TST. In addition, for the all new employees from October2011, two-step
baseline TSTs were carried out as a medical check-up at the time of employment.
QFT-GIT was performed according to the manufacturer’s instructions. A positive
QFT-GIT result was defined as the interferon-γ response of TB antigen minus the negative
control of 0.35 IU/mL and 25% of the negative control value.
Statistical analysis
Data are presented as numbers (percentage) or medians (range or interquartile range, IQR).
Pearson’s chi-squared test or Fisher’s exact test was used to comparing categorical variables,
and the Mann-Whitney U-test was used to comparing continuous variables. We used SPSS (v.
18.0; SPSS Inc., Chicago, IL, USA) in data analyzing. In all analyses, P< 0.05 (two-tailed) was
taken to indicate statistical significance.
Results
Population characteristics
A total of 458 high-risk HCWs were screened at least once by chest radiograph and TST during
the study period. The number of subjects who underwent TST screening was 286 in 2009 (T1),
172 in 2011 (T2), 119 in 2012 (T3), and 118 in 2013 (T4). A total of 695 TSTs were performed.
(Fig 1A) Also, there were 75 HCWs with two-step baseline TSTs on employment, and 97 TSTs
were performed. (Fig 1B)
The baseline characteristics of the 458 participants are presented in Table 1. The median
age of the subjects was 29 years (range 22–61 years), and 76.6% were females. Of the subjects,
55.5% were nurses, and the median duration of employment was 46.7 months. Six participants
(1.3%) reported a history of anti-TB treatment and 10 (2.2%) had abnormal findings on chest
radiographs suggestive of healed pulmonary TB.
TST results and conversion rates
Table 2 shows the summary of the screening results. The proportion of positive TST results
was 38.5% in 2009, 40.1% in 2011, 18.5% in 2012, and 22.9% in 2013. The TST conversion rate
was 30.3% from 2009 to 2011 in two years (15.2% per year), 7.4% from 2011 to 2012, and
17.4% from 2012 to 2013.
LTBI screening in healthcare workers
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For those who had negative results of two-step baseline TSTs from medical exam of recruit-
ment (N = 75), the proportion of positive TST was 27.3% in 2011, 14.3% in 2012, 19.6% in
2013. The TST conversion rate was 16.7% from 2011 to 2012, and 20.0% from 2012 to 2013.
Subjects were classified into three groups according to their TST result at the first screening
and the number of TSTs performed during follow-up. (Fig 2) Group 1 comprised 165 HCWs
with a positive TST result at the first screening; thus, these subjects did not undergo any
Table 1. Baseline characteristics of the study population.
All participants (N = 458)
Age (year), median (range) 29.1 (22–61)
20–29 237 (51.7)
30–39 131 (28.6)
40–49 60 (13.1)
50–59 29 (6.3)
60 1 (0.2)
Gender; Female 351 (76.6)
BMI (kg/m2), median (range) 20.8 (15.6–34.9)
Smoking status
Never smoker 423 (92.4)
Ex-smoker (quit 1 year) 17 (3.7)
Current smoker 18 (3.9)
Healthcare professions
Physicians 54 (11.8)
Nurses 254 (55.5)
Health aids 46 (10.0)
Laboratory staff 34 (7.4)
Radiology staff 63 (13.8)
Others 7 (1.5)
Work duration (month), median (IQR) 46.7 (18.3–178.3)
<6 month 18 (3.9)
6–24 month 124 (27.1)
24–60 month 104 (22.7)
>60 month 202 (44.1)
Work department
Outpatient 59 (12.9)
Emergency 126 (27.5)
Inpatient 166 (36.2)
Laboratory/Radiology 104 (22.7)
Comorbidities
Hypertension 16 (3.5)
Diabetes mellitus 8 (1.7)
Previously TB history 5 (1.1)
Findings on chest X-ray
Normal 448 (97.8)
Previously healed TB 10 (2.2)
Active TB 0 (0)
Data are presented as numbers (percentages) unless otherwise indicated. Abbreviations: BMI, body mass index; TB,
tuberculosis; IQR, interquartile range
https://doi.org/10.1371/journal.pone.0204035.t001
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Table 2. Summary of the screening results.
Total HCWs
(N = 458)
N TST+ % N TST Converter %
T1 (2009) 286 110 38.5
T2 (2011) 172 69 40.1 T1!T2 89 27 30.3
T3 (2012) 119 22 18.5 T2!T3 68 5 7.4
T4 (2013) 118 27 22.9 T3!T4 69 12 17.4
HCWs with two-step
baseline TSTs (N = 75)
N TST+ % N TST
Converter
%
T2 (2011) 11 3 27.3
T3 (2012) 35 5 14.3 T2!T3 6 1 16.7
T4 (2013) 51 10 19.6 T3!T4 15 3 20.0
Data are presented as numbers. Abbreviations: HCWs, healthcare workers; TST, tuberculin skin test; T1, annual screening in 2009; T2, in 2011; T3, in 2012; T4, in 2013.
https://doi.org/10.1371/journal.pone.0204035.t002
Fig 2. Follow-up for treatment of LTBI and development of active TB. Group 1 comprised HCWs with a positive TST result at their first annual screening. Group 2
comprised HCWs who underwent at least twice TSTs at the annual TB screening. Group 3 comprised HCWs with a negative TST result at their first annual screening
but who did not undergo follow-up TSTs. HCWs, healthcare workers; TST, tuberculin skin test; IGRA, interferon-γ release assay; LTBI, latent tuberculosis infection;
TB, tuberculosis.
https://doi.org/10.1371/journal.pone.0204035.g002
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further TSTs. Among them, 39 HCWs had prior TST obtained from outside medical records,
32 of which were previously negative (82% TST-converters). Out of 29 who underwent the
QFT-GIT, 5 (17.2%) HCWs showed positive results.
Group 2 comprised 151 HCWs who underwent at least two TSTs at the annual TB screen-
ing. Among them, 49 (32.4%) HCWs exhibited TST conversion during the study period. TST-
converted subjects were older and had a longer duration of employment in the hospital com-
pared to the non-converters. (Table 3) The QFT-GIT was performed in 42 of the TST-con-
verted subjects, of whom 11 (26.2%) showed positive QFT-GIT results. There were no
significant differences in characteristics between the QFT-GIT-positive and -negative groups.
Group 3 comprised 142 HCWs with a negative TST result at their first screening, but who
did not undergo follow-up TST due to department translocation, resignation, or non-
compliance.
Follow-up
We strongly recommended treatment for LTBI to the TST-converted and QFT-GIT-positive
HCWs and symptom screening and chest X-ray screening per 6 months to the TST-converted
and QFT-GIT-negative HCWs. In Group 1, four subjects completed the medication (two
received isoniazid and rifampicin for 3 months, one received rifampicin for 4 months, and one
received isoniazid for 9 months). The median follow-up duration in Group 1 was 104.5
months (IQR 65.3–104.9 months), and no case of active pulmonary TB occurred during the
follow-up.
In Group 2, eight participants started the treatment (three received isoniazid and rifampicin
for 3 months, four received rifampicin for 4 months, and one received isoniazid for 9 months),
and six completed the course. The median follow-up duration in Group 2 was 104.6 months
(IQR, 79.3–105.0 months).
Two cases of active pulmonary TB were detected by symptoms in Group 2 during the fol-
low-up period; both are TST-converted and QFT-GIT-positive nurses. One nurse completed
the treatment of LTBI with isoniazid and rifampicin for 3 months. Active pulmonary TB devel-
oped at 31 months after completion of medication. The isolated M. tuberculosis was resistant
to isoniazid, ethambutol, and streptomycin. The other nurse who did not take the medication
for LTBI was diagnosed with active pulmonary TB at 38 months after TST conversion. Isolated
M. tuberculosis was susceptible to all anti-TB medicines.
The median follow-up duration in Group 3 was 56.5 months (IQR 24.4–104.8 months).
Based on their medical records and annual medical check-up for all workers in this institution,
no case of active TB occurred in this group during the follow-up. (Fig 2)
Discussion
In this study, the rate of TST conversion in high-risk HCWs of a tertiary referral hospital in
South Korea ranged from 7.4% to 17.4% per year. The proportion of positive QFT-GIT results
in the TST-converted HCWs was 26.2%. In addition, active pulmonary TB developed only in
the TST-converted and QFT-GIT-positive subjects.
Although the current Korean TB guidelines recommend periodic screening for LTBI in
high-risk HCWs,[13] data on the annual risk of TB infection in HCWs in South Korea are lim-
ited, particularly for high-risk HCWs. According to a previous study, TST and QFT-GIT con-
version rates of nurses after one year in the Korean tertiary care hospital were 21.3% and
14.4%, respectively.[14] Another study showed that 5.7% of nurses and physicians exhibited
QFT-GIT conversion after one year of work.[15] Because of the differences in subjects’ charac-
teristics and screening methods between the current and the previous studies, we could not
LTBI screening in healthcare workers
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directly compare the risk of TB infection. However, since we focused on TB infection in high-
risk HCWs, the annual TST conversion rate of 7.4–17.4% was similar to that of newly
employed nurses. The annual incidence of TB infection in high-risk HCWs might be higher
Table 3. Comparison between converted and non-converted subjects of TST in Group 2.
All
(N = 151)
Non-conversion
(N = 102)
Conversion
(N = 49)
P-value
Age (year), median (range) 27.5 (22–61) 25.7 (22–61) 30.5 (22–56) 0.002a
20–29 87 (57.6) 67 (65.7) 20 (40.8)
30–39 38 (25.2) 17 (16.7) 21 (42.9)
40–49 18 (11.9) 15 (14.7) 3 (6.1)
50–59 7 (4.6) 2 (2.0) 5 (10.2)
60 1 (0.7) 1 (1.0) 0 (0.0)
Gender; Female 131 (86.8) 91 (89.2) 40 (81.6) 0.190b
BMI (kg/m2), median (range) 20.1 (16.4–30.5) 20.0 (16.4–27.2) 20.2 (16.6–30.5) 0.403a
Smoking status 0.660b
Never smoker 140 (92.7) 94 (92.2) 46 (93.9)
Ex-smoker (quit1 year) 5 (3.3) 3 (2.9) 2 (4.1)
Current smoker 6 (4.0) 5 (4.9) 1 (2.0)
Healthcare professions 0.470b
Physicians 10 (6.6) 4 (3.9) 6 (12.2)
Nurses 103 (68.2) 71 (69.6) 32 (65.3)
Health aides 7 (4.6) 5 (4.9) 2 (4.1)
Laboratory staffs 13 (8.6) 9 (8.8) 4 (8.2)
Radiology staffs 16 (10.6) 11 (10.8) 5 (10.2)
Others 2 (1.3) 2 (2.0) 0 (0.0)
Work duration (month), median (IQR) 69.1 (36.4–196.1) 57.5 (32.1–179.8) 87.9 (49.5–206.4) 0.034a
<6 month 0 (0) 0 (0) 0 (0)
6–24 month 18 (11.9) 15 (14.7) 3 (6.1)
24–60 month 49 (32.5) 38 (37.3) 11 (22.4)
>60 month 84 (55.6) 49 (48.0) 35 (71.4)
Work department <0.001b
Outpatient 15 (9.9) 4 (3.9) 11 (22.4)
Emergency 46 (30.5) 25 (24.5) 21 (42.9)
Inpatient 62 (41.1) 52 (51.0) 10 (20.4)
Laboratory/Radiology 28 (18.5) 21 (20.6) 7 (14.3)
Comorbidities
Hypertension 4 (2.6) 1 (1.0) 3 (6.1) 1.000b
Diabetes mellitus 2 (1.3) 2 (2.0) 0 (0) 1.000b
Baseline TST induration (mm), median (range) 0 (0–9) 0 (0–9) 1 (0–9) <0.001a
TST conversion duration (month), median (range) 25.5 (12.4–52.2)
Results of QFT-GIT
Positive 11 (26.2)
Negative 31 (73.8)
Interferon- γ concentration (IU/mL), median (IQR) 0.04 (0.01–0.71)
Data are presented as numbers (percentages) unless otherwise indicated. Abbreviations: BMI, body mass index; IQR, interquartile range; TST, tuberculin skin test;
QFT-GIT, QuantiFERON-TB Gold In-Tube.
a P-values were calculated using Mann-Whitney U-test.
b P-values were calculated using Pearson’s chi-squared test or Fisher’s exact test.
https://doi.org/10.1371/journal.pone.0204035.t003
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than that in the general population (with an expected annual risk of infection of 0.23% in
2005), although the data were not adjusted for age or sex.
In our hospital, active pulmonary TB patients are admitted in isolated rooms with negative-
pressure ventilation. Any visitors or HCWs entering the rooms must wear proper respirators
such as N95 masks. On the other hand, several patients are being diagnosed as active pulmo-
nary TB in general wards and outpatient clinic, where it is not feasible for HCWs to wear
proper protectors. In such circumstances, not only HCWs but also other patients can be placed
at high risk of TB transmission. In this point of view, we looked into a correlation between an
annual number of TB patients in this institution and TST conversion rate in high-risk HCWs,
but there was no direct relationship during the study period. The annual reported number of
pulmonary TB patients was 667 in 2011, 627 in 2012, and 435 in 2013. The TST conversion
rates were 30.3% from 2009 to 2011, 7.4% from 2011 to 2012, and 17.4% from 2012 to 2013.
TST conversion rate between 2009 and 2011 seems relatively high; possible reasons might be
on the longer interval of two years, and the boosting effect of TST, since two-step baseline
TSTs for the newly employed personnel were performed after 2011.
Discordance between TST and QFT-GIT results for LTBI diagnosis has been reported.[16]
High TST conversion rate and the low correspondence of QFT-GIT result might be con-
founded by weak immune responses and technical assay variability of IGRA.[10,17,18] The
United States Centers for Disease Control and Prevention suggested that IGRA may be used in
place of TSTs,[4] and it is preferred for BCG-vaccinated individuals.[16] However, the results
of serial IGRAs in HCWs show marked variability, and the interpretation is hampered by the
lack of consensus regarding the definition of conversion.[19,20] Thus, the optimization of the
IGRA process for reliable results is necessary.[18] In addition, the delayed boosting reaction of
repeated TST could be one explanation of discordance between high TST conversion and low
correspondence of QFT-GIT. Previous studies reported the delayed boosting reaction in two-
step baseline TST HCWs who were BCG vaccinated.[21,22]
Our protocol used both TST and QFT-GIT to screen for LTBI in high-risk HCWs. During
the near 9 years of follow-up, there were two active TB cases among TST-converted and
QFT-GIT-positive subjects, but none among TST-converted and QFT-GIT-negative group.
To our best knowledge, this is the first long-term follow-up study of active TB development in
high-risk HCWs tested periodically for LTBI in moderate to high TB burden areas.
There is still no effective method for LTBI screening in high-risk HCWs with TST-con-
verted and QFT-GIT-negative subjects. We recommend and symptom screening and chest X-
ray screening per 6 months to the TST-converted and QFT-GIT-negative HCWs and are plan-
ning to begin a serial screening with QFT-GIT in those HCWs. Since the interpretation of the
serial IGRA might be somewhat problematic, further research is needed.
This study has several limitations. First, it was conducted in a single institution with a small
number of subjects. Second, we could not perform repeated QFT-GITs in all subjects. The sub-
stantial within-subject variability associated with QFT-GIT results hampers generalization of
comparison between TST conversion and QFT-GIT results. Third, a considerable number of
subjects was lost to follow-up, likely due to transfer to another department, pregnancy, or
retirement. Fourth, because we performed two-step baseline TSTs for the newly employed
HCWs only after 2011, the TST results before that time may include boost effect. Therefore, as
mentioned above, the conversion rate from 2009 to 2011 may have been overestimated.
Finally, it is not possible to exclude the chance that the two active pulmonary TB cases were
caused by exogenous reinfection considering relatively long interval after TST conversion.
In conclusion, the TST conversion rate in high-risk HCWs of a tertiary referral hospital in a
country with an intermediate TB burden ranged from 7.4% to 17.4% per year, and less than
30% of the TST-converted subjects showed positive QFT-GIT results. Active pulmonary TB
LTBI screening in healthcare workers
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developed only in two TST-converted and QFT-GIT-positive subjects. Therefore, the com-
bined use of both TSTs and IGRAs for periodic monitoring of new TB infections in high-risk
HCWs might be useful in areas with an intermediate TB burden in which BCG vaccination is
mandatory.
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